HRES 309 · 118th Congress · Health
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the House Committee on Energy and Commerce.(2023-04-19)
Plain Language Summary
[AI summary unavailable — showing source text]
This resolution expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) has the authority to review and approve drugs pursuant to its own expertise, and that recent court decisions blocking the FDA's approval of mifepristone (which is used in medication abortion) violate congressional intent with respect to the FDA's authority.…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (20)
20 Democrats